Aura Biosciences, Inc. (AURA)
6.56
+0.27
(+4.29%)
USD |
NASDAQ |
Oct 20, 16:00
6.565
0.00 (0.00%)
After-Hours: 20:00
Aura Biosciences Net Income (Quarterly) : -45.64M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -45.64M |
| March 31, 2026 | -33.68M |
| December 31, 2025 | -25.56M |
| September 30, 2025 | -26.13M |
| June 30, 2025 | -27.02M |
| March 31, 2025 | -27.48M |
| December 31, 2024 | -25.83M |
| September 30, 2024 | -21.04M |
| June 30, 2024 | -20.34M |
| March 31, 2024 | -19.71M |
| December 31, 2023 | -22.13M |
| September 30, 2023 | -18.51M |
| June 30, 2023 | -18.30M |
| Date | Value |
|---|---|
| March 31, 2023 | -17.47M |
| December 31, 2022 | -16.56M |
| September 30, 2022 | -15.90M |
| June 30, 2022 | -13.47M |
| March 31, 2022 | -12.84M |
| December 31, 2021 | -11.63M |
| September 30, 2021 | -8.838M |
| June 30, 2021 | -8.852M |
| March 31, 2021 | -5.927M |
| December 31, 2020 | -4.907M |
| September 30, 2020 | -3.631M |
| June 30, 2020 | -6.156M |
| March 31, 2020 | -7.512M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 45.64M |
| EPS Diluted (Quarterly) | -0.4811 |
| Enterprise Value | 371.58M |
| Earnings Yield | -27.11% |
| Normalized Earnings Yield | -27.11 |